Cornercap Investment Counsel’s Integra LifeSciences IART Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-24,927
Closed -$952K 616
2023
Q3
$952K Sell
24,927
-338
-1% -$14.2K 0.17% 218
2023
Q2
$1.04M Buy
25,265
+6,771
+37% +$326K 0.18% 196
2023
Q1
$1.06M Buy
+18,494
New +$1.04M 0.19% 179
2022
Q4
Sell
-18,665
Closed -$791K 602
2022
Q3
$791K Buy
18,665
+927
+5% +$47.5K 0.15% 295
2022
Q2
$958K Buy
+17,738
New +$1.07M 0.17% 249
2022
Q1
Sell
-15,250
Closed -$1.02M 589
2021
Q4
$1.02M Sell
15,250
-758
-5% -$51.3K 0.15% 294
2021
Q3
$1.1M Buy
+16,008
New +$1.13M 0.13% 292
2021
Q1
Sell
-17,965
Closed -$1.05M 586
2020
Q4
$1.05M Buy
+17,965
New +$967K 0.15% 203
2020
Q3
Sell
-18,986
Closed -$892K 509
2020
Q2
$892K Sell
18,986
-2,319
-11% -$114K 0.14% 239
2020
Q1
$952K Buy
21,305
+915
+4% +$48K 0.19% 146
2019
Q4
$1.19M Sell
20,390
-110
-0.5% -$6.55K 0.16% 195
2019
Q3
$1.23M Buy
20,500
+15
+0.1% +$894 0.17% 165
2019
Q2
$1.14M Buy
+20,485
New +$1.05M 0.15% 199
2015
Q1
Sell
-16,930
Closed -$375K 357
2014
Q4
$375K Buy
+16,930
New +$343K 0.06% 243
2013
Q3
Sell
-114,096
Closed -$1.71M 252
2013
Q2
$1.71M Buy
+114,096
New +$1.67M 0.37% 67

Other funds holding IART

Cornercap Investment Counsel's IART Position: Q4 2023 in Review

Cornercap Investment Counsel sold out of Integra LifeSciences (IART) in Q4 2023, closing a stake of 24,927 shares — an estimated $952K sold.

Cornercap Investment Counsel first reported a position in IART in Q2 2013 and held it in 15 quarters. The position peaked at $1.71M in Q2 2013. 284 funds tracked by Wall St. Rank hold IART as of Q4 2023.

  • Cornercap Investment Counsel reported no remaining Integra LifeSciences position as of Q4 2023 after selling out during the quarter.
  • Cornercap Investment Counsel sold 24,927 Integra LifeSciences shares in Q4 2023, an estimated $952K.
  • Cornercap Investment Counsel first reported a position in Integra LifeSciences in Q2 2013 and held it in 15 quarters.
  • Cornercap Investment Counsel's Integra LifeSciences position peaked at $1.71M in Q2 2013.
  • 284 funds tracked by Wall St. Rank held Integra LifeSciences as of Q4 2023.

Based on Cornercap Investment Counsel's 13F filing for Q4 2023, filed 30 Jan 2024.